JP2006520606A - 細胞内成分の分離および蓄積、およびそれに由来するタンパク質 - Google Patents

細胞内成分の分離および蓄積、およびそれに由来するタンパク質 Download PDF

Info

Publication number
JP2006520606A
JP2006520606A JP2006507434A JP2006507434A JP2006520606A JP 2006520606 A JP2006520606 A JP 2006520606A JP 2006507434 A JP2006507434 A JP 2006507434A JP 2006507434 A JP2006507434 A JP 2006507434A JP 2006520606 A JP2006520606 A JP 2006520606A
Authority
JP
Japan
Prior art keywords
organelle
organelles
protein
biological sample
density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006507434A
Other languages
English (en)
Japanese (ja)
Inventor
ジー ローウィ，ズヴィ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wassermann Inc
Original Assignee
Alfa Wassermann Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Inc filed Critical Alfa Wassermann Inc
Publication of JP2006520606A publication Critical patent/JP2006520606A/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
JP2006507434A 2003-03-19 2004-03-19 細胞内成分の分離および蓄積、およびそれに由来するタンパク質 Abandoned JP2006520606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45576703P 2003-03-19 2003-03-19
US74131303A 2003-12-19 2003-12-19
PCT/US2004/008655 WO2004083405A2 (fr) 2003-03-19 2004-03-19 Separation et accumulation de composants sub-cellulaires, et proteines qui en sont tirees

Publications (1)

Publication Number Publication Date
JP2006520606A true JP2006520606A (ja) 2006-09-14

Family

ID=33032702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507434A Abandoned JP2006520606A (ja) 2003-03-19 2004-03-19 細胞内成分の分離および蓄積、およびそれに由来するタンパク質

Country Status (6)

Country Link
EP (1) EP1608969A4 (fr)
JP (1) JP2006520606A (fr)
KR (1) KR20050119128A (fr)
AU (1) AU2004221348A1 (fr)
CA (1) CA2518555A1 (fr)
WO (1) WO2004083405A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018514210A (ja) * 2015-04-27 2018-06-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド ハイスループットｂｈ３プロファイリング：少量の細胞でのｂｈ３プロファイルのための迅速かつ拡大縮小可能な技術
US11215608B2 (en) 2006-03-31 2022-01-04 Dana-Farber Cancer Institute, Inc. Methods of determining cellular chemosensitivity
US11225511B2 (en) 2002-09-09 2022-01-18 Howard Hughes Medical Institute BH3 peptides and methods of use thereof
US11815508B2 (en) 2012-09-19 2023-11-14 Dana-Farber Cancer Institute, Inc. Dynamic BH3 profiling
US11867687B2 (en) 2013-09-19 2024-01-09 Dana-Farber Cancer Institute, Inc. Methods of BH3 profiling

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9766207B2 (en) 2011-11-04 2017-09-19 Bio-Rad Laboratories, Inc. Affinity methods and compositions employing electronic control of pH
EP2773221B1 (fr) * 2011-11-04 2019-01-09 Bio-Rad Laboratories, Inc. Purification simultanée de composants cellulaires
US9658195B2 (en) 2012-02-15 2017-05-23 Bio-Rad Laboratories, Inc. Electronic control of pH and ionic strength
US9321012B2 (en) 2012-04-04 2016-04-26 Bio-Rad Laboratories, Inc. Electronic protein fractionation
EP3245218A4 (fr) 2015-01-13 2018-10-03 Alfa Wassermann, Inc. Procédés de purification de virus adéno-associé (aav) et/ou de virus adéno-associé recombinant (raav) et gradients et tampons de flux d'écoulement pour ceux-ci
KR20160133826A (ko) 2015-05-13 2016-11-23 고려대학교 산학협력단 전기영동을 이용한 미세소포체 분리장치
KR20160133837A (ko) 2015-05-13 2016-11-23 고려대학교 산학협력단 pH 조절 시료를 전기영동법으로 분리하기 위한 미세소포체 분리장치
US11149246B2 (en) 2016-12-29 2021-10-19 Shoreline Biome, Llc Methods for cell lysis and preparation of high molecular weight DNA from modified cells
JP6935945B2 (ja) * 2016-12-29 2021-09-15 ショアライン バイオミー エルエルシー 細胞を完全に溶解するための併用式溶解プロトコル
EP4141107A4 (fr) 2020-04-24 2024-04-17 Univ Korea Res & Bus Found Procédé d'isolement de microvésicule et dispositif d'isolation de microvésicule
CA3234817A1 (fr) * 2021-10-12 2023-04-20 Remo MOOMIAIE Systemes et procedes de fabrication de cellules therapeutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217418A (en) * 1978-05-08 1980-08-12 Merck & Co., Inc. Recovery of small particles by flow centrifugation
WO1994027698A2 (fr) * 1993-05-28 1994-12-08 Baxter International Inc. Procede de centrifugation continue destine a la separation de constituants biologiques de populations de cellules heterogenes
CA2239729C (fr) * 1995-12-11 2006-10-31 Dendreon Corporation Composition pour separation de cellules, trousse et procede associes
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US20020115056A1 (en) * 2000-12-26 2002-08-22 Goodlett David R. Rapid and quantitative proteome analysis and related methods
DE10158860B4 (de) * 2001-11-30 2007-04-05 Bruker Daltonik Gmbh Massenspektrometrische Proteingemischanalyse
US20040107057A1 (en) * 2002-03-22 2004-06-03 Capaldi Roderick A Enhanced protein separation and analysis

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11225511B2 (en) 2002-09-09 2022-01-18 Howard Hughes Medical Institute BH3 peptides and methods of use thereof
US11215608B2 (en) 2006-03-31 2022-01-04 Dana-Farber Cancer Institute, Inc. Methods of determining cellular chemosensitivity
US11815508B2 (en) 2012-09-19 2023-11-14 Dana-Farber Cancer Institute, Inc. Dynamic BH3 profiling
US11867687B2 (en) 2013-09-19 2024-01-09 Dana-Farber Cancer Institute, Inc. Methods of BH3 profiling
JP2018514210A (ja) * 2015-04-27 2018-06-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド ハイスループットｂｈ３プロファイリング：少量の細胞でのｂｈ３プロファイルのための迅速かつ拡大縮小可能な技術
US10761086B2 (en) 2015-04-27 2020-09-01 Dana-Farber Cancer Institute, Inc. High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
US11867688B2 (en) 2015-04-27 2024-01-09 Dana-Farber Cancer Institute, Inc. High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells

Also Published As

Publication number Publication date
WO2004083405A3 (fr) 2005-04-07
KR20050119128A (ko) 2005-12-20
EP1608969A4 (fr) 2007-06-06
AU2004221348A1 (en) 2004-09-30
EP1608969A2 (fr) 2005-12-28
CA2518555A1 (fr) 2004-09-30
WO2004083405A2 (fr) 2004-09-30
WO2004083405A8 (fr) 2005-11-17

Similar Documents

Publication Publication Date Title
JP2006520606A (ja) 細胞内成分の分離および蓄積、およびそれに由来するタンパク質
Stolte et al. Evolution of glucocorticoid receptors with different glucocorticoid sensitivity
Sundaramoorthy et al. Structural reorganization of the chromatin remodeling enzyme Chd1 upon engagement with nucleosomes
Murphy et al. GCP5 and GCP6: two new members of the human γ-tubulin complex
Sethi et al. Medullary amyloidosis associated with apolipoprotein A-IV deposition
Curwen et al. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages
Colca et al. Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe
US20060266715A1 (en) Separation and accumulation of subcellular components, and proteins derived therefrom
US20040110938A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
Thongboonkerd Study of diabetic nephropathy in the proteomic era
JP2004505609A (ja) 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用
JP2004532386A (ja) 多発性硬化症を診断および治療するためのタンパク質、遺伝子、およびこれらの使用
Fletcher et al. Double hexamer disruption and biochemical activities of Methanobacterium thermoautotrophicum MCM
Vertommen et al. A workflow for peptide-based proteomics in a poorly sequenced plant: a case study on the plasma membrane proteome of banana
JP2003284574A (ja) 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用
Gopalakrishnan et al. Proteomic analysis of plasma proteins in diabetic retinopathy patients by two dimensional electrophoresis and MALDI-Tof-MS
Zervou et al. Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: Structural biological insights
Surin et al. Determination of amyloid core regions of insulin analogues fibrils
WO1998019271A1 (fr) Analyse de proteome pour caracteriser des proteines a regulation positive et negative dans des echantillons biologiques
Figueiredo et al. E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer
Sparre et al. Application of genomics and proteomics in Type 1 diabetes pathogenesis research
Kumar et al. Dynactin–membrane interaction is regulated by the C‐terminal domains of p150Glued
Sun et al. Expression and characterization of the small subunit of human DNA polymerase δ
Imtiyaz et al. Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency
EP1259818A2 (fr) Diagnostic et traitement de la schizophrenie

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070309

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20071205